MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $34,000 | +25.9% | 13,445 | +2.9% | 0.00% | – |
| Q1 2020 | $27,000 | +22.7% | 13,065 | +30.9% | 0.00% | – |
| Q4 2019 | $22,000 | +83.3% | 9,980 | +23.9% | 0.00% | – |
| Q3 2019 | $12,000 | -62.5% | 8,057 | 0.0% | 0.00% | – |
| Q2 2019 | $32,000 | -5.9% | 8,057 | 0.0% | 0.00% | – |
| Q1 2019 | $34,000 | +112.5% | 8,057 | +48.6% | 0.00% | – |
| Q4 2018 | $16,000 | -70.4% | 5,421 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | +42.1% | 5,421 | 0.0% | 0.00% | – |
| Q2 2018 | $38,000 | – | 5,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |